This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Costs Associated With Lobectomy for Lung Cancer: An Analysis Merging STS and Medicare Data

Friday, May 28, 2021

Submitted by


Source Name: The Annals of Thoracic Surgery


Rachel L. Medbery, MD, Felix G. Fernandez, MD, MSc, Andrzej S. Kosinski, PhD, Betty C. Tong, MD, MHS, Anthony P. Furnary, MD, Liqi Feng, MS, Mark Onaitis, MD, Daniel Boffa, MD, Cameron D. Wright, MD, Patricia Cowper, PhD, Jeffrey P. Jacobs, MD, Joe B. Putnam, Jr, MD, and Robert H. Habib, PhD
The goal of this study was to determine underlying case mix factors that can contribute to a plethora of 90-day costs of lobectomy for early-stage lung cancer.

Add comment

Log in or register to post comments